Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: A meta-analysis

Reproductive BioMedicine Online

Volumn 19, Issue 5, 2009, Pages 619-630

  Kosmas, Ioannis P ^a   Zikopoulos, K ^a   Georgiou, I ^a   Paraskevaidis, E ^a   Blockeel, C ^b   Tournaye, H ^b   Van Der Elst, J ^b   Devroey, P ^b  

^a UNIVERSITY OF IOANNINA   (Greece)

^b CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

FSH; IVF; Low dose HCG; Meta analysis; Pregnancy rates

Indexed keywords

CHORIONIC GONADOTROPIN; GONADORELIN ANTAGONIST;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; FEMALE; FERTILIZATION IN VITRO; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; META ANALYSIS; OVARY HYPERSTIMULATION; PREGNANCY RATE; SYSTEMATIC REVIEW;

EID: 74949102002     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rbmo.2009.09.007     Document Type: Article

References (33)

1. Al-Inany HG, Abou-Setta AM, Aboulghar MA et al. 2006 HMG versus rFSH for ovulation induction in developing countries: a cost-effectiveness analysis based on the results of a recent meta-analysis. Reproductive BioMedicine Online 2, 163-169.
2. Baruffi RL, Mauri AL, Petersen CG et al. 2007 Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis. Reproductive BioMedicine Online 1, 14-25.
3. Berkkanoglu M, Isikoglu M, Aydin D et al. 2007 Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders. Fertility and Sterility 3, 665-669.
4. Chun SY, Eisenhauer KM, Minami S et al. 1996 Hormonal regulation of apoptosis in early antral follicles: follicle-stimulating hormone as a major survival factor. Endocrinology 4, 1447-1456.
5. Davies E, Check JH, Brasile JK et al. 2006 A prospective comparison of in-vitro fertilization (IVF) outcome following controlled ovarian hyperstimulation (COH) regimens using follitropin alpha exclusively or with the addition of low-dose human chorionic gonadotropin (hCG). Fertility and Sterility 85(suppl. 2), 16.
6. d'Hauterive SP, Berndt S, Tsampalas M et al. 2007 Dialogue between blastocyst hCG and endometrial LH/hCG receptor: which role in implantation? Gynecological and Obstetrical investigation 3, 156-160.
7. Dzik A, Freitas GC, De Pauwn K et al. 2006 Efficacy of low-dose HCG alone following Recombinant FSH for controlled ovarian stimulation. Fertility and Sterility 3(suppl. 1), S427.
8. Fanchin R, Righini C, Olivennes F et al. 1997 Consequences of premature progesterone elevation on the outcome of in-vitro fertilization: insights into a controversy. Fertility and Sterility 5, 799-805.
9. Fanchin R, Righini C, Olivennes F et al. 1996 Premature progesterone elevation does not alter oocyte quality in in-vitro fertilization. Fertility and Sterility 6, 1178-1183.
10. Fatum M, Gyo Y, Diana P et al. 2006 Is estradiol mandatory for an adequate follicular and embryo development? A mouse model using aromatase inhibitor (anastrozole). Journal of Assisted Reproduction and Genetics 23, 407-412.
11. Filicori M, Cognigni GE, Gamberini E et al. 2005a Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation. Fertility and Sterility 2, 394-401.
12. Filicori M, Fazleabas AT, Huhtaniemi I et al. 2005b Novel concepts of human chorionic gonadotropin: reproductive system interactions and potential in the management of infertility. Fertility and Sterility 2, 275-284.
13. Filicori M, Cognigni GE, Tabarelli C et al. 2002 Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. The Journal of Clinical Endocrinology and Metabolism 3, 1156-1161.
14. Filicori M, Cognigni GE, Taraborrelli S et al. 1999 Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertility and Sterility 6, 1118-1120.
15. Frattarelli JL, Miller KA, Kaplan B et al. 2007 Does leutinizing hormone activity in the form of low-dose HCG or HMG produce better outcomes for GNRH antagonist ART cycles stimulated with rFSH? Fertility and Sterility 88(suppl. 1), S132.
16. Garcia-Velasco JA, Coelingh Bennink HJ, Epifanio R et al. 2007 High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist. Reproductive BioMedicine Online 3, 280-287.
17. Gomes MK, Vieira CS, Moura MD et al. 2007 Controlled ovarian stimulation with exclusive FSH followed by stimulation with hCG alone, FSH alone or hMG. European Journal of Obstetrics, Gynecology and Reproductive Biology 1, 99-106.
18. Han SW, Lei ZM, Rao CV, 1999 Treatment of human endometrial stromal cells with chorionic gonadotropin promotes their morphological and functional differentiation into decidua. Molecular and Cellular Endocrinology 14, 7-16.
19. Han SW, Lei ZM, Rao CV, 1996 Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua. Endocrinology 5, 1791-1797.
20. Jasinska A, Strakova Z, Szmidt M, Fazleabas AT, 2006 Human chorionic gonadotropin and decidualization in vitro inhibits cytochalasin- D-induced apoptosis in cultured endometrial stromal fibroblasts. Endocrinology 9, 4112-4121.
21. Koichi K, Yukiko N, Shima K et al. 2006 Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol. Journal of Assisted Reproduction and Genetics 5, 223-228.
22. Kolibianakis EM, Collins J, Tarlatzis B et al. 2006 Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Human Reproduction Update 1, 3-12.
23. Kolibianakis EM, Albano C, Camus M et al. 2003 Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in-vitro fertilization cycles. The Journal of Clinical Endocrinology and Metabolism 12, 5632-5637.
24. Kosmas IP, Kolibianakis EM, Devroey P, 2004 Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. Human Reproduction 11, 2446-2453.
25. Licht P, Russu V, Wildt L, 2001 On the role of human chorionic gonadotropin (hCG) in the embryo-endometrial microenvironment: implications for differentiation and implantation. Seminars in Reproductive Medicine 1, 37-47.
26. Lovely LP, Fazleabas AT, Fritz MA et al. 2005 Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. The Journal of Clinical Endocrinology and Metabolism 4, 2351-2356.
27. Mendes IR, Kotecki JA, Caldeira G et al. 2005 Will the administration of low-dose hCG for ovulation induction in association with bromocriptine aid in the prevention of OHSS? Fertility and Sterility 84(suppl. 1), S313.
28. Mihm M, Baker PJ, Ireland JI et al. 2006 Molecular evidence that growth of dominant follicles involves a reduction in follicle-stimulating hormone dependence and an increase in luteinizing hormone dependence in cattle. Biology of Reproduction 6, 1051-1059.
29. Morris RS, Francis MM, Do YS et al. 1994 Angiotensin II (AII) modulation of steroidogenesis by luteinized granulosa cells in vitro. Journal of Assisted Reproduction and Genetics 3, 117-122.
30. Nargund G, Hutchinson L, Scaramuzzi R et al. 2007 Low-dose HCG is useful in preventing OHSS in high-risk women without adversely affecting the outcome of IVF cycles. Reproductive BioMedicine Online 6, 682-685.
31. Ruvolo G, Bosco L, Pane A et al. 2007 Lower apoptosis rate in human cumulus cells after administration of recombinant luteinizing hormone to women undergoing ovarian stimulation for in-vitro fertilization procedures. Fertility and Sterility 3, 542-546.
32. Serafini P, Yadid I, Motta EL et al. 2006 Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in-vitro fertilization: a prospective, randomized trial. Fertility and Sterility 4, 830-838.
33. Van Home AK, Bates Jr GW, Robinson RD et al., 2007 Recombinant follicle-stimulating hormone (rFSH) supplemented with low-dose human chorionic gonadotropin compared with rFSH alone for ovarian stimulation for in-vitro fertilization. Fertility and Sterility 4, 1010-1013.